HALO
Ticker
Halozyme Therapeutics, Inc.
HALO · Healthcare · Halozyme Therapeutics, Inc., a biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in th…Halozyme Therapeutics, Inc. (HALO), in the Healthcare sector, has 23 disclosed filings on Paydirt over the trailing twelve months from 1 member of Congress and 6 corporate insiders: 1 purchase and 22 sales, 1 filed past the deadline. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Sep 16 and filed Sep 17. The most active filer was Helen Torley with 17 filings.
Add to watchlistFilings, ttm
23
1 buy · 22 sells · 1 late
Traders, ttm
7
1 congress · 6 insiders
Volume, ttmiDollar value disclosed in the window
$44.7M
estimated for Congress, as filed for insiders
Median delay
2d
execution to disclosure
Last traded
Sep 16
Filed Sep 17
ADViAverage daily dollar volume
$214.5M
market data
Share price · 12M
$107 (+36.8%)
Adjusted for splits and dividends.
Volume by month
Buys $8K
Sells $65.6M
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed
HTRecent filings
Matthew L. PosardSALE
Director
$2.0M18,996 sh across 4 lots
Exec Sep 16
Filed Sep 17 · 5:19 PM ET Helen TorleySALE PRESIDENT AND CEO $6.4M
59,900 sh across 6 lots
Exec Sep 9
Filed Sep 11 · 8:35 PM ET Helen TorleySALE PRESIDENT AND CEO $6.1M
58,600 sh across 9 lots
Exec Aug 17
Filed Aug 19 · 8:01 PM ET Bernadette ConnaughtonSALE Director $167K
1,626 sh × $102.80
Exec Aug 10
Filed Aug 11 · 5:43 PM ET Mahesh KrishnanSALE Director $548K
7,304 sh × $75.00
Exec Jun 29
Filed Jun 30 · 5:30 PM ET Helen TorleySALE PRESIDENT AND CEO $3.3M
49,600 sh across 8 lots
Exec Jun 1
Filed Jun 3 · 5:30 PM ET Bernadette ConnaughtonSALE Director $108K
1,625 sh × $66.21
Exec Jun 1
Filed Jun 2 · 5:30 PM ET Helen TorleySALE PRESIDENT AND CEO $3.3M
47,902 sh across 9 lots
Exec May 11
Filed May 13 · 5:30 PM ET Bernadette ConnaughtonSALE Director $103K
1,625 sh × $63.48
Exec May 1
Filed May 5 · 5:30 PM ET Helen TorleySALE PRESIDENT AND CEO $635K
10,000 sh across 2 lots
Exec Apr 6
Filed Apr 7 · 5:30 PM ET Gilbert CisnerosPURCHASE Representative $8K
$1K–15K bracket
Exec Mar 9
Filed Apr 7 Helen TorleySALE PRESIDENT AND CEO $2.5M
39,000 sh across 3 lots
Exec Apr 1
Filed Apr 2 · 5:30 PM ET Cortney CaudillSALE SVP, CHIEF OPERATING OFFICER $2.0M
28,857 sh across 3 lots
Exec Mar 9
Filed Mar 10 · 5:30 PM ET Helen TorleySALE PRESIDENT AND CEO $3.4M
49,422 sh across 6 lots
Exec Mar 2
Filed Mar 4 · 5:30 PM ET Helen TorleySALE PRESIDENT AND CEO $3.9M
50,000 sh across 7 lots
Exec Feb 3
Filed Feb 5 · 5:30 PM ET Bernadette ConnaughtonSALE Director $140K
2,000 sh × $70.25
Exec Jan 5
Filed Jan 6 · 5:30 PM ET Cortney CaudillSALE SVP, CHIEF OPERATING OFFICER $278K
4,263 sh × $65.19
Exec Nov 1 2025
Filed Dec 19 2025 · 5:30 PM ET † Helen TorleySALE PRESIDENT AND CEO $1.1M
15,808 sh across 2 lots
Exec Dec 1 2025
Filed Dec 1 2025 · 5:30 PM ET Bernadette ConnaughtonSALE Director $137K
2,000 sh × $68.48
Exec Nov 10 2025
Filed Nov 12 2025 · 5:30 PM ET Helen TorleySALE PRESIDENT AND CEO $4.1M
59,402 sh across 6 lots
Exec Nov 10 2025
Filed Nov 12 2025 · 5:30 PM ET Helen TorleySALE PRESIDENT AND CEO $4.2M
58,476 sh across 8 lots
Exec Oct 1 2025
Filed Oct 3 2025 · 5:30 PM ET Bernadette ConnaughtonSALE Director $113K
1,500 sh × $75.09
Exec Oct 1 2025
Filed Oct 1 2025 · 5:30 PM ET Nicole LaBrosseSALE SVP, CHIEF FINANCIAL OFFICER $149K
1,913 sh × $77.83
Exec Sep 22 2025
Filed Sep 23 2025 · 5:30 PM ET Nicole LaBrosseSALE SVP, CHIEF FINANCIAL OFFICER $1.5M
20,000 sh across 2 lots
Exec Sep 10 2025
Filed Sep 11 2025 · 5:30 PM ET Helen TorleySALE PRESIDENT AND CEO $4.4M
59,700 sh across 7 lots
Exec Sep 2 2025
Filed Sep 4 2025 · 5:30 PM ET